Viewing nowCombinationTelmisartan 40/5 mg Tablets
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
DaeWon Biotech Co., Ltd.

MFDS item code 201908431 · Approved 2019.12.16 · Insurance code 057600480
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension, also known as high blood pressure, may be treated with combination therapy when blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. These medications effectively lower blood pressure, reduce stress on the heart and blood vessels, and help decrease the risk of complications. Thus, these medications are used for patients with essential hypertension who have difficulty controlling blood pressure.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medication; however, direct conversion to this medication may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medication (a combination product containing the same strengths of each active ingredient) for convenience (limited to this medication 40/5 milligrams). ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution during administration’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so it should not be used while pregnant. It is important to stop taking this medication as soon as pregnancy is confirmed. This medication should not be taken by individuals with allergies to it or those with certain heart diseases, liver dysfunction, or severe hypotension. Nursing mothers should also avoid this medication. Patients with poor liver function or gastrointestinal diseases, as well as those with kidney diseases, should use this medication cautiously. Special care is needed for the elderly and heart failure patients. Side effects such as dizziness, swelling, and low blood pressure may occur while taking this medication, and if any unusual symptoms arise, consultation with a physician is advised. Due to the strong blood pressure-lowering effects, immediate appropriate actions should be taken if symptoms of hypotension occur. There may be interactions when taking this medication with others, so it is essential to inform your physician about any other medications being taken. Caution should be exercised while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as low blood pressure, dizziness, and heart issues may arise, requiring immediate medical attention. This medication is not recommended for children, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, it should be kept at room temperature between 1°C and 30°C, away from excessively hot or cold environments.
A biconvex elliptical double-layer tablet, white and light gray in color.
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
DaeWon Biotech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.